In last trading session, BioAffinity Technologies Inc (NASDAQ:BIAF) saw 0.48 million shares changing hands with its beta currently measuring 2.74. Company’s recent per share price level of $0.99 trading at -$0.19 or -15.86% at ring of the bell on the day assigns it a market valuation of $15.47M. That closing price of BIAF’s stock is at a discount of -265.66% from its 52-week high price of $3.62 and is indicating a premium of 16.16% from its 52-week low price of $0.83. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.17 million shares which gives us an average trading volume of 140.47K if we extend that period to 3-months.

BioAffinity Technologies Inc (NASDAQ:BIAF) trade information

Upright in the red during last session for losing -15.86%, in the last five days BIAF remained trading in the green while hitting it’s week-highest on Friday, 12/20/24 when the stock touched $0.99 price level, adding 23.26% to its value on the day. BioAffinity Technologies Inc’s shares saw a change of -32.49% in year-to-date performance and have moved 6.75% in past 5-day. BioAffinity Technologies Inc (NASDAQ:BIAF) showed a performance of -21.83% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 1.43 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.28% during past 5 years.

BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders

Insiders are in possession of 29.55% of company’s total shares while institution are holding 3.03 percent of that, with stock having share float percentage of 4.29%. Investors also watch the number of corporate investors in a company very closely, which is 3.03% institutions for BioAffinity Technologies Inc that are currently holding shares of the company.